Human Gene MIR135B (ENST00000362189.3) from GENCODE V44
|
|
Sequence and Links to Tools and Databases
|
|
Primer design for this transcript
|
|
Comparative Toxicogenomics Database (CTD)
|
|
The following chemicals interact with this gene
| |
|
|
RNA-Seq Expression Data from GTEx (53 Tissues, 570 Donors)
|
|
Microarray Expression Data
|
|
Press "+" in the title bar above to open this section.
| |
|
|
Orthologous Genes in Other Species
|
|
Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
Mouse | Rat | Zebrafish | D. melanogaster | C. elegans | S. cerevisiae |
No ortholog | No ortholog | No ortholog | No ortholog | No ortholog | No ortholog |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
|
| |
|
|
Descriptions from all associated GenBank mRNAs
|
|
CS266597 - Sequence 289 from Patent WO2005118806. DL076759 - METHODS AND COMPOSITIONS INVOLVING MicroRNA. DM004409 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. FW421751 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HW367622 - JP 2012228254-A/289: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HW412015 - JP 2014000079-A/289: METHODS AND COMPOSITIONS INVOLVING MicroRNA. HW674361 - JP 2014217381-A/289: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HZ067303 - JP 2014012020-A/289: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HZ427727 - JP 2014217384-A/289: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HZ428530 - JP 2014217385-A/289: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HZ429333 - JP 2014217386-A/289: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HZ430136 - JP 2014217387-A/289: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HZ769393 - JP 2014223080-A/289: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. JA058787 - Sequence 289 from Patent EP2298893. JA059590 - Sequence 289 from Patent EP2298894. JA073913 - Sequence 289 from Patent EP2281887. JA105050 - Sequence 289 from Patent EP2302051. JA106390 - Sequence 289 from Patent EP2302052. JA107193 - Sequence 289 from Patent EP2302053. JA107996 - Sequence 289 from Patent EP2302054. JA108799 - Sequence 289 from Patent EP2302055. JA109602 - Sequence 289 from Patent EP2302056. JA192118 - Sequence 289 from Patent EP2290066. JA193017 - Sequence 289 from Patent EP2290067. JA193916 - Sequence 289 from Patent EP2290068. JA194815 - Sequence 289 from Patent EP2290069. JA195714 - Sequence 289 from Patent EP2290070. JA196613 - Sequence 289 from Patent EP2290071. JA197512 - Sequence 289 from Patent EP2290072. JA198411 - Sequence 289 from Patent EP2290073. JA199310 - Sequence 289 from Patent EP2290074. JA200209 - Sequence 289 from Patent EP2290075. JA201108 - Sequence 289 from Patent EP2290076. JA218230 - Sequence 289 from Patent EP2281888. JA226381 - Sequence 289 from Patent EP2292755. JA229236 - Sequence 289 from Patent EP2292756. JA257507 - Sequence 289 from Patent EP2284265. JA278787 - Sequence 289 from Patent EP2281886. JA284673 - Sequence 289 from Patent EP2281889. JA292726 - Sequence 289 from Patent EP2287303. JA317912 - Sequence 289 from Patent EP2314688. JA374971 - Sequence 289 from Patent EP2322616. JC221814 - Sequence 289 from Patent EP2471923. JC268380 - Sequence 289 from Patent EP2471924. JC340688 - Sequence 289 from Patent EP2471922. JC469934 - Sequence 289 from Patent EP2471921. JC990723 - Sequence 289 from Patent EP2808390. LF714826 - JP 2016165292-A/289: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. LF856760 - JP 2015142597-A/289: METHODS AND COMPOSITIONS INVOLVING MicroRNA. CS266408 - Sequence 100 from Patent WO2005118806. DL076570 - METHODS AND COMPOSITIONS INVOLVING MicroRNA. DM004220 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. FU261184 - MICRORNA EXPRESSION ABNORMALITIES IN PANCREATIC ENDOCRINE AND ACINAR TUMORS. FU763686 - MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS. FV525906 - Nucleic acid controling mast cell degranulation. FW421562 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HH932827 - Sequence 39 from Patent EP2239675. HV304585 - JP 2009531018-A/152: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF LUNG CANCER. HV305083 - JP 2009531019-A/152: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS. HV970152 - JP 2012523000-A/39: Method for in vitro Diagnosing a Complex Disease. HW119292 - JP 2013046612-A/152: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS. HW367433 - JP 2012228254-A/100: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HW411826 - JP 2014000079-A/100: METHODS AND COMPOSITIONS INVOLVING MicroRNA. HW505126 - JP 2014502606-A/28: MELANOMA TREATMENTS. HW589621 - JP 2013121348-A/152: MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS. HW674172 - JP 2014217381-A/100: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HW799999 - JP 2014530803-A/60: MICRO-RNAS AND COMPOSITIONS COMPRISING SAME FOR THE TREATMENT AND DIAGNOSIS OF SEROTONIN-, ADRENALIN-, NORADRENALIN-, GLUTAMATE-, AND CORTICOTROPIN-RELEASING HORMONE-ASSOCIATED MEDICAL CONDITIONS. HZ043283 - JP 2015510401-A/373: MESENCHYMAL STEM CELLS FOR IN VITRO MODELING AND CELL-BASED THERAPY OF HUMAN DISEASES AND BANKS THEREOF. HZ067114 - JP 2014012020-A/100: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HZ081909 - JP 2015514392-A/373: MicroRNAS FOR THE GENERATION OF ASTROCYTES. HZ408279 - JP 2015528002-A/876: CHIRAL CONTROL. HZ413425 - JP 2014060993-A/152: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS. HZ427538 - JP 2014217384-A/100: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HZ428341 - JP 2014217385-A/100: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HZ429144 - JP 2014217386-A/100: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HZ429947 - JP 2014217387-A/100: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HZ501636 - JP 2016025853-A/152: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS. HZ769204 - JP 2014223080-A/100: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. JA058598 - Sequence 100 from Patent EP2298893. JA059401 - Sequence 100 from Patent EP2298894. JA073724 - Sequence 100 from Patent EP2281887. JA104861 - Sequence 100 from Patent EP2302051. JA106201 - Sequence 100 from Patent EP2302052. JA107004 - Sequence 100 from Patent EP2302053. JA107807 - Sequence 100 from Patent EP2302054. JA108610 - Sequence 100 from Patent EP2302055. JA109413 - Sequence 100 from Patent EP2302056. JA191929 - Sequence 100 from Patent EP2290066. JA192828 - Sequence 100 from Patent EP2290067. JA193727 - Sequence 100 from Patent EP2290068. JA194626 - Sequence 100 from Patent EP2290069. JA195525 - Sequence 100 from Patent EP2290070. JA196424 - Sequence 100 from Patent EP2290071. JA197323 - Sequence 100 from Patent EP2290072. JA198222 - Sequence 100 from Patent EP2290073. JA199121 - Sequence 100 from Patent EP2290074. JA200020 - Sequence 100 from Patent EP2290075. JA200919 - Sequence 100 from Patent EP2290076. JA218041 - Sequence 100 from Patent EP2281888. JA226192 - Sequence 100 from Patent EP2292755. JA229047 - Sequence 100 from Patent EP2292756. JA257318 - Sequence 100 from Patent EP2284265. JA278598 - Sequence 100 from Patent EP2281886. JA284484 - Sequence 100 from Patent EP2281889. JA292537 - Sequence 100 from Patent EP2287303. JA317723 - Sequence 100 from Patent EP2314688. JA374782 - Sequence 100 from Patent EP2322616. JA526002 - Sequence 152 from Patent EP2369011. JA526509 - Sequence 152 from Patent EP2369012. JA527016 - Sequence 152 from Patent EP2369013. JA535945 - Sequence 152 from Patent EP2371971. JA787950 - Sequence 152 from Patent EP2479285. JA788448 - Sequence 152 from Patent EP2479286. JA810782 - Sequence 152 from Patent EP2468890. JA811280 - Sequence 152 from Patent EP2468891. JA811778 - Sequence 152 from Patent EP2468893. JA812276 - Sequence 152 from Patent EP2468894. JA812774 - Sequence 152 from Patent EP2468895. JA813272 - Sequence 152 from Patent EP2468896. JA813770 - Sequence 152 from Patent EP2468897. JA814268 - Sequence 152 from Patent EP2468898. JA814766 - Sequence 152 from Patent EP2468899. JA817009 - Sequence 152 from Patent EP2468892. JA825821 - Sequence 152 from Patent EP2471956. JA826319 - Sequence 152 from Patent EP2471958. JB024606 - Sequence 152 from Patent EP2505668. JB025104 - Sequence 152 from Patent EP2505669. JB079491 - Sequence 152 from Patent EP2487252. JB079989 - Sequence 152 from Patent EP2487253. JB080487 - Sequence 152 from Patent EP2487254. JB080985 - Sequence 152 from Patent EP2487255. JB081483 - Sequence 152 from Patent EP2487256. JB081981 - Sequence 152 from Patent EP2487257. JB082479 - Sequence 152 from Patent EP2487258. JB082977 - Sequence 152 from Patent EP2487259. JB083475 - Sequence 152 from Patent EP2487260. JB083973 - Sequence 152 from Patent EP2487261. JB084471 - Sequence 152 from Patent EP2487262. JB084969 - Sequence 152 from Patent EP2487263. JB087647 - Sequence 152 from Patent EP2502630. JB147851 - Sequence 152 from Patent EP2484782. JB148349 - Sequence 152 from Patent EP2484783. JB153074 - Sequence 152 from Patent EP2514433. JB153572 - Sequence 152 from Patent EP2514434. JB622161 - Sequence 152 from Patent EP2586454. JB622659 - Sequence 152 from Patent EP2586455. JC001722 - Sequence 152 from Patent EP2591794. JC221625 - Sequence 100 from Patent EP2471923. JC268191 - Sequence 100 from Patent EP2471924. JC340499 - Sequence 100 from Patent EP2471922. JC469745 - Sequence 100 from Patent EP2471921. JC990534 - Sequence 100 from Patent EP2808390. JE972009 - Sequence 60 from Patent WO2015118537. LF404380 - JP 2015509366-A/373: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS. LF714637 - JP 2016165292-A/100: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. LF856571 - JP 2015142597-A/100: METHODS AND COMPOSITIONS INVOLVING MicroRNA. LG051613 - KR 1020150036642-A/879: CHIRAL CONTROL. LP765572 - Sequence 1 from Patent EP3276009. LP883651 - Sequence 60 from Patent EP3208338. LX145683 - JP 2017506228-A/60: MICRO-RNAS AND COMPOSITIONS COMPRISING SAME FOR THE TREATMENT AND DIAGNOSIS OF SEROTONIN-, ADRENALIN-, NORADRENALIN-, GLUTAMATE-, AND CORTICOTROPIN-RELEASING HORMONE-ASSOCIATED MEDICAL CONDITIONS. LX245240 - JP 2017095482-A/60: MICRO-RNAS AND COMPOSITIONS COMPRISING SAME FOR THE TREATMENT AND DIAGNOSIS OF SEROTONIN-, ADRENALIN-, NORADRENALIN-, GLUTAMATE-, AND CORTICOTROPIN-RELEASING HORMONE-ASSOCIATED MEDICAL CONDITIONS. MA353911 - JP 2018075017-A/373: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS. MP045551 - Sequence 373 from Patent EP3401394. MP084221 - Sequence 373 from Patent EP3401393. JD020576 - Sequence 1600 from Patent EP1572962. FW364003 - Oligonucleotides for modulating target RNA activity. HI560925 - Sequence 140 from Patent EP2190992. HI965447 - Sequence 732 from Patent WO2010139812. HI966290 - Sequence 610 from Patent WO2010139811. HI967156 - Sequence 610 from Patent WO2010139810. HV594026 - JP 2010538653-A/140: MIRNA EXPRESSION IN HUMAN PERIPHERAL BLOOD MICROVESICLES AND USES THEREOF. HV594886 - JP 2010539959-A/267: Micromirs. HW505495 - JP 2014502606-A/397: MELANOMA TREATMENTS. HZ074234 - JP 2013535982-A/325: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer. HZ082848 - JP 2015513906-A/205: Stem Cell Microparticles. HZ157443 - JP 2015130862-A/267: Micromirs. HZ186316 - JP 2015146814-A/65: Oligonucleotides for modulating target RNA activity. HZ436629 - JP 2015529450-A/205: Stem Cell Microparticles. HZ479790 - JP 2015535430-A/296: TERMINALLY MODIFIED RNA. HZ789721 - JP 2016504050-A/1466: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. JA401485 - Sequence 732 from Patent WO2011080318. JA402463 - Sequence 732 from Patent WO2011080315. JA403470 - Sequence 732 from Patent WO2011080316. JA406101 - Sequence 732 from Patent EP2336353. JA427085 - Sequence 418 from Patent WO2011072177. JA429627 - Sequence 732 from Patent WO2011095623. JA660641 - Sequence 95 from Patent WO2011131354. JA808535 - Sequence 7 from Patent WO2012083969. JB620410 - Sequence 390 from Patent WO2013063544. JB624320 - Sequence 140 from Patent EP2610342. JB835738 - Sequence 28 from Patent WO2013057567. JC171833 - Sequence 205 from Patent WO2013150303. JC244610 - Sequence 230 from Patent WO2012020308. JC512453 - Sequence 2706 from Patent WO2014113089. JC572644 - Sequence 205 from Patent WO2014125276. JC582332 - Sequence 205 from Patent WO2014125277. JE954028 - Sequence 205 from Patent WO2015052526. JE955781 - Sequence 205 from Patent WO2015052527. JE972142 - Sequence 193 from Patent WO2015118537. JE978650 - Sequence 95 from Patent EP2865765. LF137533 - JP 2016507550-A/205: Method of Producing Microparticles. LF161888 - JP 2016513950-A/1954: Oligomers with improved off-target profile. LF162498 - JP 2016513095-A/205: Stem Cell Microparticles and miRNA. LF953250 - JP 2016534103-A/205: Stem Cell Microparticles and miRNA. LG005595 - KR 1020150004822-A/205: STEM CELL MICROPARTICLES. LG053291 - KR 1020150059168-A/205: STEM CELL MICROPARTICLES. LG240530 - KR 1020160035087-A/205: STEM CELL MICROPARTICLES AND MIRNA. LP726916 - Sequence 610 from Patent EP2883966. LP819186 - Sequence 610 from Patent EP3296406. LP939128 - Sequence 610 from Patent EP3184651. LQ070041 - Sequence 365 from Patent EP2964234. LV470615 - JP 2016534036-A/205: Stem Cell Microparticles and miRNA. LX145816 - JP 2017506228-A/193: MICRO-RNAS AND COMPOSITIONS COMPRISING SAME FOR THE TREATMENT AND DIAGNOSIS OF SEROTONIN-, ADRENALIN-, NORADRENALIN-, GLUTAMATE-, AND CORTICOTROPIN-RELEASING HORMONE-ASSOCIATED MEDICAL CONDITIONS. LY404951 - KR 1020160117535-A/256: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES. LZ233673 - JP 2017184756-A/65: Oligonucleotides for modulating target RNA activity. MA260190 - JP 2017505623-A/256: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES. MA405728 - WO 2018155427-A/502: A probe with reduced false positive binding, a method to desing the probe, and the use thereof. MA643542 - JP 2017113010-A/1466: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. MA731426 - JP 2017140048-A/296: TERMINALLY MODIFIED RNA. MP014813 - Sequence 16 from Patent WO2019016252. MS833435 - Sequence 140 from Patent EP3112464. MS834586 - Sequence 732 from Patent EP3112479. JD034191 - Sequence 15215 from Patent EP1572962. FW364002 - Oligonucleotides for modulating target RNA activity. HI560924 - Sequence 139 from Patent EP2190992. HI965448 - Sequence 733 from Patent WO2010139812. HI965902 - Sequence 222 from Patent WO2010139811. HI966768 - Sequence 222 from Patent WO2010139810. HV593870 - JP 2010538610-A/83: MICRORNA SIGNATURES IN HUMAN OVARIAN CANCER. HV594025 - JP 2010538653-A/139: MIRNA EXPRESSION IN HUMAN PERIPHERAL BLOOD MICROVESICLES AND USES THEREOF. HV594885 - JP 2010539959-A/266: Micromirs. HW289791 - JP 2013520158-A/34: REENGINEERING MRNA PRIMARY STRUCTURE FOR ENHANCED PROTEIN PRODUCTION. HW505315 - JP 2014502606-A/217: MELANOMA TREATMENTS. HW669835 - JP 2013537538-A/566: THERAPEUTIC USES OF MICROVESICLES AND RELATED MICRORNAS. HW800001 - JP 2014530803-A/62: MICRO-RNAS AND COMPOSITIONS COMPRISING SAME FOR THE TREATMENT AND DIAGNOSIS OF SEROTONIN-, ADRENALIN-, NORADRENALIN-, GLUTAMATE-, AND CORTICOTROPIN-RELEASING HORMONE-ASSOCIATED MEDICAL CONDITIONS. HW913445 - JP 2015504307-A/205: METHODS OF DIAGNOSING AND TREATING IDIOPATHIC PULMONARY FIBROSIS. HZ043172 - JP 2015510401-A/262: MESENCHYMAL STEM CELLS FOR IN VITRO MODELING AND CELL-BASED THERAPY OF HUMAN DISEASES AND BANKS THEREOF. HZ074233 - JP 2013535982-A/324: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer. HZ081798 - JP 2015514392-A/262: MicroRNAS FOR THE GENERATION OF ASTROCYTES. HZ082780 - JP 2015513906-A/137: Stem Cell Microparticles. HZ157442 - JP 2015130862-A/266: Micromirs. HZ186315 - JP 2015146814-A/64: Oligonucleotides for modulating target RNA activity. HZ392528 - JP 2015180203-A/34: REENGINEERING MRNA PRIMARY STRUCTURE FOR ENHANCED PROTEIN PRODUCTION. HZ436561 - JP 2015529450-A/137: Stem Cell Microparticles. HZ479791 - JP 2015535430-A/297: TERMINALLY MODIFIED RNA. HZ789722 - JP 2016504050-A/1467: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. JA401486 - Sequence 733 from Patent WO2011080318. JA402464 - Sequence 733 from Patent WO2011080315. JA403471 - Sequence 733 from Patent WO2011080316. JA406102 - Sequence 733 from Patent EP2336353. JA426795 - Sequence 128 from Patent WO2011072177. JA429628 - Sequence 733 from Patent WO2011095623. JA791948 - Sequence 350 from Patent WO2012089772. JA808551 - Sequence 23 from Patent WO2012083969. JB022448 - Sequence 290 from Patent WO2013026685. JB023070 - Sequence 324 from Patent WO2013026684. JB050095 - Sequence 182 from Patent WO2013020926. JB175263 - Sequence 295 from Patent WO2012101219. JB620409 - Sequence 389 from Patent WO2013063544. JB624319 - Sequence 139 from Patent EP2610342. JB778826 - Sequence 205 from Patent WO2013078283. JB835759 - Sequence 49 from Patent WO2013057567. JC171765 - Sequence 137 from Patent WO2013150303. JC244609 - Sequence 229 from Patent WO2012020308. JC270175 - Sequence 566 from Patent WO2012020307. JC512454 - Sequence 2707 from Patent WO2014113089. JC572576 - Sequence 137 from Patent WO2014125276. JC582264 - Sequence 137 from Patent WO2014125277. JE953960 - Sequence 137 from Patent WO2015052526. JE955713 - Sequence 137 from Patent WO2015052527. JE972011 - Sequence 62 from Patent WO2015118537. LF137465 - JP 2016507550-A/137: Method of Producing Microparticles. LF161587 - JP 2016513950-A/1653: Oligomers with improved off-target profile. LF162430 - JP 2016513095-A/137: Stem Cell Microparticles and miRNA. LF404269 - JP 2015509366-A/262: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS. LF636367 - JP 2016519076-A/141: COMBINATION CANCER TREATMENTS UTILIZING MICRORNA AND EGFR-TKI INHIBITORS. LF857634 - JP 2015130879-A/83: MICRORNA SIGNATURES IN HUMAN OVARIAN CANCER. LF953182 - JP 2016534103-A/137: Stem Cell Microparticles and miRNA. LG005527 - KR 1020150004822-A/137: STEM CELL MICROPARTICLES. LG053223 - KR 1020150059168-A/137: STEM CELL MICROPARTICLES. LG134524 - KR 1020150131312-A/142: COMBINATION CANCER TREATMENTS UTILIZING MICRORNAS AND EGFR-TKI INHIBITORS. LG240462 - KR 1020160035087-A/137: STEM CELL MICROPARTICLES AND MIRNA. LP726528 - Sequence 222 from Patent EP2883966. LP818798 - Sequence 222 from Patent EP3296406. LP883653 - Sequence 62 from Patent EP3208338. LP917444 - Sequence 40 from Patent WO2017153710. LP938740 - Sequence 222 from Patent EP3184651. LQ070042 - Sequence 366 from Patent EP2964234. LQ420443 - Sequence 19 from Patent WO2016127998. LQ500669 - Sequence 83 from Patent EP3048177. LQ844120 - Sequence 40 from Patent WO2018138468. LQ955752 - Sequence 83 from Patent EP2775001. LV470547 - JP 2016534036-A/137: Stem Cell Microparticles and miRNA. LV539181 - JP 2016539127-A/182: C/EBP ALPHA COMPOSITIONS AND METHODS OF USE. LX145685 - JP 2017506228-A/62: MICRO-RNAS AND COMPOSITIONS COMPRISING SAME FOR THE TREATMENT AND DIAGNOSIS OF SEROTONIN-, ADRENALIN-, NORADRENALIN-, GLUTAMATE-, AND CORTICOTROPIN-RELEASING HORMONE-ASSOCIATED MEDICAL CONDITIONS. LX245242 - JP 2017095482-A/62: MICRO-RNAS AND COMPOSITIONS COMPRISING SAME FOR THE TREATMENT AND DIAGNOSIS OF SEROTONIN-, ADRENALIN-, NORADRENALIN-, GLUTAMATE-, AND CORTICOTROPIN-RELEASING HORMONE-ASSOCIATED MEDICAL CONDITIONS. LX270632 - JP 2016056210-A/566: THERAPEUTIC USES OF MICROVESICLES AND RELATED MICRORNAS. LY298583 - KR 1020160079824-A/182: C/EBP ALPHA SHORT ACTIVATING RNA COMPOSITIONS AND METHODS OF USE. LY404950 - KR 1020160117535-A/255: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES. LZ233672 - JP 2017184756-A/64: Oligonucleotides for modulating target RNA activity. MA260189 - JP 2017505623-A/255: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES. MA267278 - JP 2018061445-A/12: Method for detecting urothelial cancer based on microRNA in urine using cell sorting. MA353800 - JP 2018075017-A/262: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS. MA643543 - JP 2017113010-A/1467: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. MA730779 - JP 2017125065-A/566: THERAPEUTIC USES OF MICROVESICLES AND RELATED MICRORNAS. MA731427 - JP 2017140048-A/297: TERMINALLY MODIFIED RNA. MA765546 - JP 2017514519-A/112: Small ncRNAs as biomarkers. MP045440 - Sequence 262 from Patent EP3401394. MP070451 - Sequence 48 from Patent WO2018231851. MP084110 - Sequence 262 from Patent EP3401393. MS673521 - Sequence 324 from Patent EP3135774. MS833434 - Sequence 139 from Patent EP3112464. MS834587 - Sequence 733 from Patent EP3112479. MS901817 - Sequence 290 from Patent EP3156505. MS904167 - Sequence 83 from Patent EP3138926. CS548274 - Sequence 1304 from Patent EP1777301. DJ003758 - Method for predicting or identifying target mRNAs of functional RNAs and use thereof. DJ027037 - Method for predicting or identifying target mRNAs of functional RNAs and use thereof. FU261422 - MICRORNA EXPRESSION ABNORMALITIES IN PANCREATIC ENDOCRINE AND ACINAR TUMORS. FU763924 - MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS. FV524350 - Nucleic acid controling mast cell degranulation. FW312014 - DETECTING NUCLEIC ACIDS. FZ415738 - JP 2010536372-A/18: METHODS OF USING MIRNA FOR DETECTION OF IN VIVO CELL DEATH. HI548975 - Sequence 38 from Patent EP2187900. HV304823 - JP 2009531018-A/390: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF LUNG CANCER. HV305321 - JP 2009531019-A/390: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS. HV954045 - JP 2012518421-A/957: METHODS OF DETECTING LUNG CANCER. HW119530 - JP 2013046612-A/390: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS. HW589859 - JP 2013121348-A/390: MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS. HZ413663 - JP 2014060993-A/390: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS. HZ501874 - JP 2016025853-A/390: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS. HZ883160 - JP 2016065089-A/22: Therapeutic Compositions For Treatment of Inflammation of Ocular and Adnexal Tissues. JA526240 - Sequence 390 from Patent EP2369011. JA526747 - Sequence 390 from Patent EP2369012. JA527254 - Sequence 390 from Patent EP2369013. JA536183 - Sequence 390 from Patent EP2371971. JA715175 - Sequence 957 from Patent EP2401406. JA788188 - Sequence 390 from Patent EP2479285. JA788686 - Sequence 390 from Patent EP2479286. JA811020 - Sequence 390 from Patent EP2468890. JA811518 - Sequence 390 from Patent EP2468891. JA812016 - Sequence 390 from Patent EP2468893. JA812514 - Sequence 390 from Patent EP2468894. JA813012 - Sequence 390 from Patent EP2468895. JA813510 - Sequence 390 from Patent EP2468896. JA814008 - Sequence 390 from Patent EP2468897. JA814506 - Sequence 390 from Patent EP2468898. JA815004 - Sequence 390 from Patent EP2468899. JA817247 - Sequence 390 from Patent EP2468892. JA826059 - Sequence 390 from Patent EP2471956. JA826557 - Sequence 390 from Patent EP2471958. JB024844 - Sequence 390 from Patent EP2505668. JB025342 - Sequence 390 from Patent EP2505669. JB079729 - Sequence 390 from Patent EP2487252. JB080227 - Sequence 390 from Patent EP2487253. JB080725 - Sequence 390 from Patent EP2487254. JB081223 - Sequence 390 from Patent EP2487255. JB081721 - Sequence 390 from Patent EP2487256. JB082219 - Sequence 390 from Patent EP2487257. JB082717 - Sequence 390 from Patent EP2487258. JB083215 - Sequence 390 from Patent EP2487259. JB083713 - Sequence 390 from Patent EP2487260. JB084211 - Sequence 390 from Patent EP2487261. JB084709 - Sequence 390 from Patent EP2487262. JB085207 - Sequence 390 from Patent EP2487263. JB087885 - Sequence 390 from Patent EP2502630. JB148089 - Sequence 390 from Patent EP2484782. JB148587 - Sequence 390 from Patent EP2484783. JB153312 - Sequence 390 from Patent EP2514433. JB153810 - Sequence 390 from Patent EP2514434. JB622399 - Sequence 390 from Patent EP2586454. JB622897 - Sequence 390 from Patent EP2586455. JC001960 - Sequence 390 from Patent EP2591794. JC334116 - Sequence 34 from Patent EP2487240. LQ978379 - Sequence 6 from Patent WO2013040251. LX058148 - JP 2011516400-A/22: Therapeutic Compositions For Treatment of Inflammation of Ocular and Adnexal Tissues. FZ421162 - JP 2010539978-A/62: INCREASING ERYTHROPOIETIN USING NUCLEIC ACIDS HYBRIDIZABLE TO MICRO-RNA AND PRECURSORS THEREOF. HW502476 - JP 2014050389-A/62: INCREASING ERYTHROPOIETIN USING NUCLEIC ACIDS HYBRIDIZABLE TO MICRO-RNA AND PRECURSORS THEREOF. MA800595 - JP 2018183181-A/1466: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. MA800596 - JP 2018183181-A/1467: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. MP129305 - Sequence 205 from Patent EP3470073. MP162228 - Sequence 205 from Patent WO2019069093. MP129237 - Sequence 137 from Patent EP3470073. MP162160 - Sequence 137 from Patent WO2019069093. MB018390 - JP 2018504915-A/19: A microRNA-based method for early detection of prostate cancer in urine samples. MP262556 - Sequence 60 from Patent EP3524679. MP264009 - Sequence 3 from Patent WO2019086603. MP262558 - Sequence 62 from Patent EP3524679. MP280735 - Sequence 155 from Patent WO2019111197. MP283648 - Sequence 155 from Patent WO2019111198. MB471143 - JP 2019172696-A/60: MICRO-RNAS AND COMPOSITIONS COMPRISING SAME FOR THE TREATMENT AND DIAGNOSIS OF SEROTONIN-, ADRENALIN-, NORADRENALIN-, GLUTAMATE-, AND CORTICOTROPIN-RELEASING HORMONE-ASSOCIATED MEDICAL CONDITIONS. MB471276 - JP 2019172696-A/193: MICRO-RNAS AND COMPOSITIONS COMPRISING SAME FOR THE TREATMENT AND DIAGNOSIS OF SEROTONIN-, ADRENALIN-, NORADRENALIN-, GLUTAMATE-, AND CORTICOTROPIN-RELEASING HORMONE-ASSOCIATED MEDICAL CONDITIONS. MB453612 - JP 2018509178-A/178: Methods for Highly Parallel and Accurate Measurement of Nucleic Acids. MB471145 - JP 2019172696-A/62: MICRO-RNAS AND COMPOSITIONS COMPRISING SAME FOR THE TREATMENT AND DIAGNOSIS OF SEROTONIN-, ADRENALIN-, NORADRENALIN-, GLUTAMATE-, AND CORTICOTROPIN-RELEASING HORMONE-ASSOCIATED MEDICAL CONDITIONS.
| |
|
|
Other Names for This Gene
|
|
Alternate Gene Symbols: ENST00000362189.1, ENST00000362189.2, NR_029893, uc010prh.1, uc010prh.2, uc010prh.3 UCSC ID: ENST00000362189.3 RefSeq Accession: NR_029893
| |
|
|
Methods, Credits, and Use Restrictions
|
|
Click here
for details on how this gene model was made and data restrictions if any.
| |
|
|
|